Endocrine tumours of the pancreas: Review and recent advances
dc.contributor.author | Mullan, Michelle H. | en_US |
dc.contributor.author | Gauger, Paul G. | en_US |
dc.contributor.author | Thompson, Norman W. | en_US |
dc.date.accessioned | 2010-06-01T22:04:50Z | |
dc.date.available | 2010-06-01T22:04:50Z | |
dc.date.issued | 2001-08-04 | en_US |
dc.identifier.citation | Mullan, Michelle H.; Gauger, Paul G.; Thompson, Norman W. (2001). "Endocrine tumours of the pancreas: Review and recent advances." ANZ Journal of Surgery 71(8): 475-482. <http://hdl.handle.net/2027.42/75105> | en_US |
dc.identifier.issn | 1445-1433 | en_US |
dc.identifier.issn | 1445-2197 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75105 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11504292&dopt=citation | en_US |
dc.format.extent | 905741 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Pty | en_US |
dc.rights | Royal Australasian College of Surgeons | en_US |
dc.subject.other | Endoscopic Ultrasound | en_US |
dc.subject.other | Multiple Endocrine Neoplasia-1 | en_US |
dc.subject.other | Pancreatic Endocrine Tumours | en_US |
dc.subject.other | Review | en_US |
dc.subject.other | Somatostatin Receptor Scintigraphy | en_US |
dc.title | Endocrine tumours of the pancreas: Review and recent advances | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Surgery, Division of Endocrine Surgery, University of Michigan Hospital, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 11504292 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75105/1/j.1440-1622.2001.02191.x.pdf | |
dc.identifier.doi | 10.1046/j.1440-1622.2001.02191.x | en_US |
dc.identifier.source | ANZ Journal of Surgery | en_US |
dc.identifier.citedreference | Wilder RM, Allan FN, Power MH et al. Carcinoma of the islets of the pancreas: Hyperinsulinism and hypoglycemia. JAMA 1927; 89: 348 – 55. | en_US |
dc.identifier.citedreference | Whipple AO & Franz VK. Adenoma of islet cells with hyperinsulinism. Am. Surg. 1935; 101: 1299 – 935. | en_US |
dc.identifier.citedreference | Grant CS. Gastrointestinal endocrine tumours. Insulinoma. Baillieres Clin. Gastroenterol. 1996; 10: 645 – 71. | en_US |
dc.identifier.citedreference | Proye C, Pattou F, Carnaille B et al. Intraoperative insulin measurement during surgical management of insulinomas. World J. Surg. 1998; 22: 1218 – 24. | en_US |
dc.identifier.citedreference | Fong TL, Warner NE, Kumar D. Pancreatic nesidioblastosis in adults. Diabetes Care 1989; 12: 108 – 14. | en_US |
dc.identifier.citedreference | Zollinger RM & Ellison EH. Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann. Surg. 1955; 142: 709 – 23. | en_US |
dc.identifier.citedreference | Gregory RA, Tracy HJ, French JM et al. Extraction of a gastrin-like substance from a pancreatic tumor in a case of Zollinger– Ellison syndrome. Lancet 1960; 1: 1045 – 8. | en_US |
dc.identifier.citedreference | Thompson NW, Vinik AI, Eckhauser FE. Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger– Ellison syndrome. Ann. Surg. 1989; 209: 396 – 404. | en_US |
dc.identifier.citedreference | Thompson NW, Pasieka J, Fukuuchi A. Duodenal gastrinomas, duodenotomy and duodenal exploration in the surgical management of Zollinger–Ellison syndrome. World J. Surg. 1993; 17: 455 – 62. | en_US |
dc.identifier.citedreference | Prinz RA, Badrinath K, Banerji M et al. Operative and chemotheraputic management of malignant producing tumors. Surgery 1981; 90: 713 – 19. | en_US |
dc.identifier.citedreference | Wiedenmann B, Jensen RT, Mignon M et al. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumours: General recommendations by a consensus workshop. World J. Surg. 1998; 22: 309 – 18. | en_US |
dc.identifier.citedreference | Rothmund M, Stinner B, Arnold R. Endocrine pancreatic carcinoma. Eur. J. Surg. Oncol. 1991; 17: 191 – 9. | en_US |
dc.identifier.citedreference | Bieligk S & Jaffe BM. Islet cell tumors of the pancreas. Surg. Clin. North Am. 1995; 75: 1025 – 40. | en_US |
dc.identifier.citedreference | Reynolds C, Pratt R, Chan-Yan C. Somatostatinoma: The most recently described pancreatic islet cell tumor. West. J. Med. 1985; 142: 393 – 7. | en_US |
dc.identifier.citedreference | Maton PN, Gardner JD, Jensen RT. Use of long-acting somatostatin analog SMS201-995 in patients with pancreatic islet cell tumors. Dig. Dis. Sci. 1989; 34: S28 – S39. | en_US |
dc.identifier.citedreference | Declore R & Friesen SR. Gastrointestinal neuroendocrine tumors. J. Am. Coll Surg. 1994; 178: 187 – 211. | en_US |
dc.identifier.citedreference | Mozell E, Stenzel P, Woltering E et al. Functional endocrine tumors of the pancreas: Clinical presentation, diagnosis, and treatment. Curr. Probl. Surg. 1990; 27: 303 – 86. | en_US |
dc.identifier.citedreference | Moertel CG, Hanley JA, Johnson LA. Streptozotocin alone compared with streptozotocin plus 5-fluorouracil in the treatment of advanced islet cell carcinoma. N. Engl. J. Med. 1980; 303: 1189 – 94. | en_US |
dc.identifier.citedreference | Eriksson B, Oberg K, Alan G et al. Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon. Lancet 1986; 2: 1307 – 9. | en_US |
dc.identifier.citedreference | Jensen RT. Pancreatic endocrine tumors: Recent advances. Ann. Oncol. 1999; 10: S170 – S176. | en_US |
dc.identifier.citedreference | Chandrasekharappa SC, Guru SC, Manickam P et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997; 276: 404 – 6. | en_US |
dc.identifier.citedreference | Thompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the MEN type1 patient. J. Intern. Med. 1995; 238: 269 – 80. | en_US |
dc.identifier.citedreference | Teh BT. Thymic carcinoids in multiple endocrine neoplasia type 1. J. Intern. Med. 1998; 243: 501 – 4. | en_US |
dc.identifier.citedreference | van Heerden JA, Smith SL, Miller LJ. Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1. Surgery 1986; 100: 971 – 6. | en_US |
dc.identifier.citedreference | Mignon M, Ruszniewski P, Podevin P et al. Current approach to the management of a gastrinoma and insulinoma in adults with multiple endocrine neoplasia I. World J. Surg. 1993; 17: 489 – 97. | en_US |
dc.identifier.citedreference | Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic duodenal disease. Results in the treatment of 40 patients with Zollinger– Ellison syndrome, hypoglycaemia or both. J. Intern. Med. 1998; 243: 495 – 500. | en_US |
dc.identifier.citedreference | Moore NR, Rogers CE, Britton BJ. Magnetic resonance imaging of endocrine tumours of the pancreas. Br. J. Radiol. 1995; 68: 341 – 7. | en_US |
dc.identifier.citedreference | Catalano C, Pavone P, Laghi A et al. Localization of pancreatic insulinomas with MR imaging at 0.5T. Acta Radiol. 1999; 40: 644 – 8. | en_US |
dc.identifier.citedreference | Gibril F, Reynolds JC, Doppman JL et al. Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: A prospective study. Ann. Intern. Med. 1996; 125: 26 – 34. | en_US |
dc.identifier.citedreference | Krenning EP, Kwekkeboom DJ, Bakker WH et al. Somatostatin receptor scintigraphy with [ 111 In-DTPA-D-Phe 1 ]- and [ 123 I-Tyr 3 ]-octreotide: The Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 1993; 20: 716 – 31. | en_US |
dc.identifier.citedreference | Norton JA, Fraker DL, Alexander HR et al. Surgery to cure Zollinger–Ellison syndrome. N. Engl. J. Med. 1999; 341: 635 – 44. | en_US |
dc.identifier.citedreference | Zimmer T, StÖlzer U, BÄder M et al. Endoscopic ultrasonography and somatotstatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 1996; 39: 562 – 8. | en_US |
dc.identifier.citedreference | RÖsch T, Lightdale CJ, Botet JF et al. Localization of pancreatic endocrine tumors by endoscopic ultrasound. N. Engl. J. Med. 1992; 326: 1721 – 6. | en_US |
dc.identifier.citedreference | Thompson NW, Czako PF, Fritts LL et al. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery 1994; 116: 1131 – 8. | en_US |
dc.identifier.citedreference | Proye C, Malvaux P, Pattou F et al. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery 1998; 124: 1134 – 44. | en_US |
dc.identifier.citedreference | Rothmund M. Localization of endocrine pancreatic tumours. Br. J. Surg. 1994; 81: 164 – 6. | en_US |
dc.identifier.citedreference | Lo CY, Lam KY, Kung AW et al. Pancreatic insulinomas: A 15 year experience. Arch. Surg. 1997; 132: 926 – 30. | en_US |
dc.identifier.citedreference | Doppman JL. Pancreatic endocrine tumors: The search goes on. N. Engl. J. Med. 1992; 326: 1770 – 2. | en_US |
dc.identifier.citedreference | Lo CY, Chan FL, Tam SCF et al. Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery 2000; 128: 903 – 9. | en_US |
dc.identifier.citedreference | Doherty GM, Doppman JL, Shawker TH et al. Results of a prospective strategy to diagnose, localize, and resect insulinoma. Surgery 1992; 110: 989 – 97. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.